UM

Uday Mohan Raghavan

Director Additional Director DIN 01817707
DIN 01817707 First appointment Sep 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Uday Mohan Raghavan

Data last updated:

Uday Mohan Raghavan was an Additional Director at Zoetis India Limited (2009–2010) and Director at Duchem Laboratories Limited (from 2007). The companies operate in Pharma.

DIN 01817707
Primary Designation Additional Director
Industry Pharma
First Appointment 01 Sep 2007
Oldest Company Age 68 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zoetis India Limited U46497MH2007PLC203686
Additional Director01 Dec 20092007₹402 Cr (FY 2025)Active
Duchem Laboratories Limited U74300MH1958PLC011117
Director01 Sep 20071958Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Duchem Laboratories Limited
Zoetis India Limited
Premium access

Shareholding and investment profile for Uday Mohan Raghavan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uday Mohan Raghavan

Uday Mohan Raghavan was first appointed on 01 Sep 2007 as Director at Duchem Laboratories Limited. The most recent appointment on record is 01 Dec 2009 at Zoetis India Limited.

Uday Mohan Raghavan held 2 earlier board appointments: Zoetis India Limited (Additional Director, 01 Dec 2009 to 29 Sep 2010); Duchem Laboratories Limited (Director, from 01 Sep 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available